CrystalGenomics, Inc. (083790.KQ)

KRW 2545.0

(0.99%)

Gross Profit Summary of CrystalGenomics, Inc.

  • CrystalGenomics, Inc.'s latest annual gross profit in 2023 was 1.45 Billion KRW , up 16.05% from previous year.
  • CrystalGenomics, Inc.'s latest quarterly gross profit in 2024 Q2 was 313.55 Million KRW , up 398.12% from previous quarter.
  • CrystalGenomics, Inc. reported a annual gross profit of 1.25 Billion KRW in annual gross profit 2022, down -94.22% from previous year.
  • CrystalGenomics, Inc. reported a annual gross profit of 21.7 Billion KRW in annual gross profit 2021, up 68.13% from previous year.
  • CrystalGenomics, Inc. reported a quarterly gross profit of -105.17 Million KRW for 2024 Q1, up 98.77% from previous quarter.
  • CrystalGenomics, Inc. reported a quarterly gross profit of 1.45 Billion USD for 2023 FY, up 16.05% from previous quarter.

Annual Gross Profit Chart of CrystalGenomics, Inc. (2023 - 2013)

Historical Annual Gross Profit of CrystalGenomics, Inc. (2023 - 2013)

Year Gross Profit Gross Profit Growth
2023 1.45 Billion KRW 16.05%
2022 1.25 Billion KRW -94.22%
2021 21.7 Billion KRW 68.13%
2020 12.91 Billion KRW 102.85%
2019 4.8 Billion KRW 6.55%
2018 10.98 Billion KRW 4.08%
2017 8.84 Billion KRW 2.33%
2016 9.66 Billion KRW 5.29%
2015 5.81 Billion KRW 7.95%
2014 4.53 Billion KRW 4.09%
2013 4.79 Billion KRW 0.0%

Peer Gross Profit Comparison of CrystalGenomics, Inc.

Name Gross Profit Gross Profit Difference
HLB Co., Ltd. -6.01 Billion KRW 124.233%
iNtRON Biotechnology, Inc. 4.56 Billion KRW 68.054%
BINEX Co., Ltd. 56.65 Billion KRW 97.428%
Bioneer Corporation 199.25 Billion KRW 99.269%
Anterogen.Co.,Ltd. 2.21 Billion KRW 34.175%
MEDIPOST Co., Ltd. 40.18 Billion KRW 96.374%
Helixmith Co., Ltd 2.12 Billion KRW 31.333%
Chabiotech Co.,Ltd. 255.19 Billion KRW 99.429%
Medy-Tox Inc. 128.16 Billion KRW 98.863%
Peptron, Inc. 1.14 Billion KRW -27.743%
Amicogen, Inc. 51.51 Billion KRW 97.172%
Genexine, Inc. 387.48 Million KRW -276.016%
HLB Therapeutics Co.,Ltd. 6.69 Billion KRW 78.235%
LegoChem Biosciences, Inc. 17.79 Billion KRW 91.813%
ALTEOGEN Inc. 31.19 Billion KRW 95.33%
PharmaResearch Co., Ltd. 182.25 Billion KRW 99.201%
SillaJen, Inc. 1.45 Billion KRW -0.018%
JETEMA, Co., Ltd. 26.58 Billion KRW 94.519%
OliX Pharmaceuticals,Inc 14.42 Billion KRW 89.898%
Genomictree Inc. -1.03 Billion KRW 240.286%
MedPacto, Inc. -1.83 Billion KRW 179.502%
D&D Pharmatech 18.67 Billion KRW 92.199%
EASY BIO,Inc. 50.88 Billion KRW 97.137%
GI Innovation, Inc. 1.98 Billion KRW 26.762%